AMAG - AMAG Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5523.54M
Enterprise Value 3868.94M
Trailing P/E N/A
Forward P/E 1-4.97
PEG Ratio (5 yr expected) 10.06
Price/Sales (ttm)0.87
Price/Book (mrq)0.65
Enterprise Value/Revenue 31.44
Enterprise Value/EBITDA 64.02

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin -35.35%
Operating Margin (ttm)16.00%

Management Effectiveness

Return on Assets (ttm)2.68%
Return on Equity (ttm)-24.54%

Income Statement

Revenue (ttm)603.2M
Revenue Per Share (ttm)17.35
Quarterly Revenue Growth (yoy)6.90%
Gross Profit (ttm)415.2M
EBITDA 216.35M
Net Income Avi to Common (ttm)-213.24M
Diluted EPS (ttm)-6.13
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)394.1M
Total Cash Per Share (mrq)11.14
Total Debt (mrq)755.42M
Total Debt/Equity (mrq)94.39
Current Ratio (mrq)1.59
Book Value Per Share (mrq)22.63

Cash Flow Statement

Operating Cash Flow (ttm)149.17M
Levered Free Cash Flow (ttm)159.65M

Trading Information

Stock Price History

Beta 0.71
52-Week Change 3-41.31%
S&P500 52-Week Change 323.26%
52 Week High 325.20
52 Week Low 311.93
50-Day Moving Average 314.19
200-Day Moving Average 316.56

Share Statistics

Avg Vol (3 month) 3849.88k
Avg Vol (10 day) 3754.84k
Shares Outstanding 535.37M
Float 29M
% Held by Insiders 11.74%
% Held by Institutions 1119.86%
Shares Short 39.25M
Short Ratio 38.23
Short % of Float 336.28%
Shares Short (prior month) 39.14M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 23/2
Last Split Date 3Sep 26, 1991